Osteoporosis management in patients with chronic kidney disease (ERCOS Study) : A challenge in nephrological care
Copyright © 2024. Published by Elsevier España, S.L.U..
Fracture risk assessment in patients with chronic kidney disease (CKD) has been included in the CKD-MBD ("Chronic Kidney Disease-Mineral and Bone Disorders") complex in international and national nephrology guidelines, suggesting for the first time the assessment of bone mineral density (BMD) if the results can influence therapeutic decision-making. However, there is very little information on actual clinical practice in this population. The main objective of the ERCOS (ERC-Osteoporosis) study is to describe the profile of patients with CKD G3-5D with osteoporosis (OP) and/or fragility fractures treated in specialized nephrology, rheumatology and internal medicine clinics in Spain. Fifteen centers participated and 162 patients (mostly women [71.2%] postmenopausal [98.3%]) with a median age of 77 years were included. Mean estimated glomerular filtration rate (eGFR) was 36 mL/min/1.73 m2 and 38% of the included patients were on dialysis. We highlight the high frequency of prevalent fragility fractures [37.7%), mainly vertebral (52.5%) and hip (24.6%)], the disproportionate history of patients with glomerular disease compared to purely nephrological series (corticosteroids) and undertreatment for fracture prevention, especially in nephrology consultations. This study is an immediate call to action with the dissemination of the new, more proactive, clinical guidelines, and underlines the need to standardize a coordinated and multidisciplinary care/therapeutic approach to these patients in an efficient way to avoid current discrepancies and therapeutic nihilism.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Nefrologia - (2024) vom: 25. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bover, Jordi [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 26.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.nefroe.2024.03.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370213203 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370213203 | ||
| 003 | DE-627 | ||
| 005 | 20240328000758.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240328s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nefroe.2024.03.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1351.xml |
| 035 | |a (DE-627)NLM370213203 | ||
| 035 | |a (NLM)38531765 | ||
| 035 | |a (PII)S2013-2514(24)00063-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bover, Jordi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Osteoporosis management in patients with chronic kidney disease (ERCOS Study) |b A challenge in nephrological care |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024. Published by Elsevier España, S.L.U. | ||
| 520 | |a Fracture risk assessment in patients with chronic kidney disease (CKD) has been included in the CKD-MBD ("Chronic Kidney Disease-Mineral and Bone Disorders") complex in international and national nephrology guidelines, suggesting for the first time the assessment of bone mineral density (BMD) if the results can influence therapeutic decision-making. However, there is very little information on actual clinical practice in this population. The main objective of the ERCOS (ERC-Osteoporosis) study is to describe the profile of patients with CKD G3-5D with osteoporosis (OP) and/or fragility fractures treated in specialized nephrology, rheumatology and internal medicine clinics in Spain. Fifteen centers participated and 162 patients (mostly women [71.2%] postmenopausal [98.3%]) with a median age of 77 years were included. Mean estimated glomerular filtration rate (eGFR) was 36 mL/min/1.73 m2 and 38% of the included patients were on dialysis. We highlight the high frequency of prevalent fragility fractures [37.7%), mainly vertebral (52.5%) and hip (24.6%)], the disproportionate history of patients with glomerular disease compared to purely nephrological series (corticosteroids) and undertreatment for fracture prevention, especially in nephrology consultations. This study is an immediate call to action with the dissemination of the new, more proactive, clinical guidelines, and underlines the need to standardize a coordinated and multidisciplinary care/therapeutic approach to these patients in an efficient way to avoid current discrepancies and therapeutic nihilism | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a BMD | |
| 650 | 4 | |a Bone mineral density | |
| 650 | 4 | |a CKD-MBD | |
| 650 | 4 | |a Chronic kidney disease | |
| 650 | 4 | |a Chronic kidney disease-mineral and bone disorder | |
| 650 | 4 | |a DXA | |
| 650 | 4 | |a Densidad mineral ósea | |
| 650 | 4 | |a Densitometry | |
| 650 | 4 | |a Densitometría | |
| 650 | 4 | |a Enfermedad renal crónica | |
| 650 | 4 | |a Enfermedad renal crónica-trastorno del metabolismo mineral y óseo | |
| 650 | 4 | |a Fractura | |
| 650 | 4 | |a Fracture | |
| 650 | 4 | |a Osteoporosis | |
| 650 | 4 | |a Tratamiento | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Gómez-Alonso, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Casado, Enrique |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-García, Minerva |e verfasserin |4 aut | |
| 700 | 1 | |a Lloret, María Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Castro-Alonso, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Gifre, Laia |e verfasserin |4 aut | |
| 700 | 1 | |a Henríquez-Palop, Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Prior-Español, Águeda |e verfasserin |4 aut | |
| 700 | 1 | |a López de la Manzanara, Virginia |e verfasserin |4 aut | |
| 700 | 1 | |a Láiz, Ana María |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Ferrer, Àngels |e verfasserin |4 aut | |
| 700 | 1 | |a Torregrosa, Josep Vicens |e verfasserin |4 aut | |
| 700 | 1 | |a Cigarrán, Secundino |e verfasserin |4 aut | |
| 700 | 1 | |a Górriz, José Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Montomoli, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Panizo, Nayara |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Ester |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Laguna, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez, Mariano |e verfasserin |4 aut | |
| 700 | 1 | |a Navarro-González, Juan F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nefrologia |d 2018 |g (2024) vom: 25. März |w (DE-627)NLM270991409 |x 2013-2514 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:25 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nefroe.2024.03.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 25 |c 03 | ||